Semaglutide for Smoking Cessation in Patients With Diabetes

Clinical trial NCT07059377 · RECRUITING

Trial details

NCT number: NCT07059377
Sponsor: Ottawa Heart Institute Research Corporation
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Nicotine Addiction Tobacco Dependence

Start date: 2026-02-13
Primary completion: 2026-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.